Invitae 2023 Strategic Business Realignment Investor Presentation

Invitae Corporation presented preliminary 2022 financial results and outlined its strategic business realignment initiatives aimed at bringing comprehensive genetic information into mainstream medicine. The presentation discusses the company's roadmap, cost-efficiency improvements, and expected benefits of its business transformation on the path to profitability.